@article{QIMS25199,
author = {Heng Liu and Haoxiang Jiang and Xiaoyu Wang and Jie Zheng and Huifang Zhao and Yannan Cheng and Xingxing Tao and Miaomiao Wang and Congcong Liu and Ting Huang and Liang Wu and Chao Jin and Xianjun Li and Hui Wang and Jian Yang},
title = {Treatment response prediction of rehabilitation program in children with cerebral palsy using radiomics strategy: protocol for a multicenter prospective cohort study in west China},
journal = {Quantitative Imaging in Medicine and Surgery},
volume = {9},
number = {8},
year = {2019},
keywords = {},
abstract = {Background: Cerebral palsy (CP) is a major cause of chronic childhood disability worldwide, causing activity limitation as well as impairments in sensation, cognition, and communication. Leveraging biomarkers to establish individualized predictions of future treatment responses will be of great value. We aim to develop and validate a model that can be used to predict the individualized treatment response in Children with CP.
Methods: A multicenter prospective cohort study will be conducted in 4 hospitals in west China. One hundred and thirty children with CP will be recruited and undergo clinical assessment using the Peabody Developmental Motor Scales, Manual Ability Classification System (MACS), Hand Assessment for Infants (HAI), Assisting Hand Assessment (AHA), and Gross Motor Function Classification System (GMFCS). The data collected will include MRI image, clinical status, and socioeconomic status. The clinical information and MRI features extracted using radiomics strategy will be combined for exploratory analysis. The accuracy, sensitivity, and specificity of the model will be assessed using multiple modeling methodologies. Internal and external validation will be used to evaluate the performance of the radiomics model.
Discussion: We hypothesized that the findings from this study could provide a critical step towards the prediction of treatment response in children with CP, which could also complement other biomarkers in the development of precision medicine approaches for this severe disorder.
Trial registration: The study was registered with clinicaltrials.gov (NCT02979743).},
issn = {2223-4306}, url = {https://qims.amegroups.org/article/view/25199}
}